Number 5: The FDA has approved Pavblu (aflibercept-ayyh), the fifth biosimilar referencing Eylea (aflibercept).1 The new ...

Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are taking place. Peter ...

Private credit more than doubled in size from 2019 thanks to interest rate hikes that made its floating-rate debt more ...

After hours: September 19 at 7:48 PM EDT Loading Chart for TAK ...

3382.T Seven & i Holdings Co., Ltd.

After hours: 16 September at 19:30 GMT-4 ...

The buyout firm owners of German generic-drug maker Stada Arzneimittel AG have been working on a possible sale and GTCR is in advanced talks on a potential acquisition that could value the business at ...

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, discusses the challenges of expanding biosimilars into new therapeutic areas and highlights the role of ...